The market price of MCX has outperformed the market in the past 12 months by surging 20 per cent as against 0.95 per cent gain in the S&P BSE Sensex. It should be pointed out that the writ petitions filed by CFMA on CDP are pending before the Madras High Court for disposal. Sebi has advised the exchange to keep the proposed Go-Live of CDP in abeyance, MCX said in a statement. As the Exchange is ready and keen to go-live as soon as allowed, the Exchange will continue to conduct CDP mock tests till further directions in the matter from Sebi, MCX said. Investors at HDFC Securities maintain a 'buy' rating on MCX with a target price of 2,400 per share.